J&J Racing to Develop Ebola Vaccine: Stoffels

Oct. 22 (Bloomberg) -- Paul Stoffels, chief scientific officer at Johnson & Johnson, talks about the company's plans to have 250,000 doses of experimental Ebola vaccine ready for clinical trials in May. He speaks with Matt Miller, Erik Schatzker and Shannon Pettypiece on Bloomberg Television's "Market Makers." (Source: Bloomberg)

How to Trade Biotech Stocks With the IBB
10:46 - Kevin Kelly, Kelly & Co. managing partner, discusses equity market volatility and his options play for biotech stocks. He speaks with Bloomberg's Julie Hyman on "Bloomberg Markets." (Source: Bloomberg)
  • The Winners and Losers Among Activist Shareholders
  • Blue Apron Implements Temporary Hiring Freeze
  • Why Mark Cuban Wants in on the Cryptocurrency Boom